Medifast, Inc. (0K05.L)
USD 18.48
(-0.75%)
USD 18.48
(-0.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.07 Billion | 1.59 Billion | 1.52 Billion | 934.84 Million | 713.67 Million | 501 Million |
| Cost of Revenue | 296.2 Million | 458.16 Million | 398.49 Million | 237.02 Million | 176.81 Million | 121.1 Million |
| Gross Profit | 775.85 Million | 1.14 Billion | 1.12 Billion | 697.81 Million | 536.85 Million | 379.89 Million |
| Operating Expenses | 649.44 Million | 955.6 Million | 911.35 Million | 563.65 Million | 445.81 Million | 310.83 Million |
| Selling, General and Administrative Expenses | 649.44 Million | 955.6 Million | 911.35 Million | 563.65 Million | 445.81 Million | 310.83 Million |
| Research and Development Expenses | 4.6 Million | 4.5 Million | 4.4 Million | 2.8 Million | 2.7 Million | 2.2 Million |
| Other Expenses | - | -46 Thousand | 119 Thousand | -140 Thousand | 29 Thousand | 179 Thousand |
| Cost and Expenses | 945.65 Million | 1.41 Billion | 1.3 Billion | 800.68 Million | 622.63 Million | 431.94 Million |
| Operating Income | 126.4 Million | 184.8 Million | 216.24 Million | 134.15 Million | 91.03 Million | 69.06 Million |
| Interest Expense | - | 701 Thousand | 231 Thousand | - | - | 1.3 Million |
| Income Tax Expense | 29.38 Million | 40.49 Million | 52.09 Million | 31.4 Million | 14.44 Million | 14.75 Million |
| Earnings before Tax | 128.79 Million | 184.05 Million | 216.12 Million | 134.26 Million | 92.36 Million | 70.54 Million |
| Net Income | 99.41 Million | 143.56 Million | 164.03 Million | 102.85 Million | 77.91 Million | 55.78 Million |
| Earnings Per Share Basic | 9.13 | 12.82 | 14.01 | 8.74 | 6.62 | 4.67 |
| Earnings Per Share Diluted | 9.10 | 12.73 | 13.89 | 8.68 | 6.43 | 4.62 |
| Weighted Average Shares Outstanding | 10.88 Million | 11.19 Million | 11.7 Million | 11.77 Million | 11.77 Million | 11.94 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.92 Million | 11.27 Million | 11.81 Million | 11.85 Million | 12.11 Million | 12.07 Million |
| Gross Margin | 0.72 | 0.71 | 0.74 | 0.75 | 0.75 | 0.76 |
| EBIT Margin | 0.13 | 0.12 | 0.15 | 0.14 | 0.13 | 0.14 |
| Profit Margin | 0.09 | 0.09 | 0.11 | 0.11 | 0.11 | 0.11 |
| EBITDA | 139.5 Million | 201.83 Million | 223.05 Million | 134.15 Million | 95.66 Million | 73.49 Million |
| Earnings Before Tax Margin | 0.12 | 0.12 | 0.14 | 0.14 | 0.13 | 0.14 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 140.16 Million | 168.55 Million | 174.73 Million | 191.01 Million | 1.07 Billion | 235.86 Million |
| Cost of Revenue | 34.48 Million | 45.12 Million | 47.44 Million | 49.64 Million | 296.2 Million | 58.49 Million |
| Gross Profit | 105.67 Million | 123.43 Million | 127.29 Million | 141.36 Million | 775.85 Million | 177.37 Million |
| Operating Expenses | 103.56 Million | 131.31 Million | 119.35 Million | 132.69 Million | 649.44 Million | 151.86 Million |
| Selling, General and Administrative Expenses | 103.56 Million | 130.21 Million | 118.35 Million | 132.69 Million | - | 151.86 Million |
| Research and Development Expenses | 1.1 Million | 1.1 Million | 1 Million | 1.2 Million | - | 1.3 Million |
| Other Expenses | - | -4.07 Million | 2.42 Million | -50 Thousand | -95 Thousand | 7000.00 |
| Cost and Expenses | 138.05 Million | 176.43 Million | 166.79 Million | 182.33 Million | 945.65 Million | 210.36 Million |
| Operating Income | 2.1 Million | -7.87 Million | 7.94 Million | 8.67 Million | 126.4 Million | 25.5 Million |
| Interest Expense | - | - | 1.22 Million | - | 2.49 Million | 1.03 Million |
| Income Tax Expense | 449 Thousand | -2.49 Million | 3.26 Million | 3.76 Million | 29.38 Million | 3.41 Million |
| Earnings before Tax | 1.57 Million | -10.65 Million | 11.58 Million | 9.8 Million | 128.79 Million | 26.54 Million |
| Net Income | 1.12 Million | -8.15 Million | 8.31 Million | 6.03 Million | 99.41 Million | 23.13 Million |
| Earnings Per Share Basic | 0.10 | -0.75 | 0.76 | 0.55 | - | 2.12 |
| Earnings Per Share Diluted | 0.10 | -0.75 | 0.76 | 0.55 | - | 2.12 |
| Weighted Average Shares Outstanding | 10.93 Million | 10.93 Million | 10.9 Million | 10.89 Million | 10.88 Million | 10.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.97 Million | 10.93 Million | 10.95 Million | 10.93 Million | 10.92 Million | 10.93 Million |
| Gross Margin | 0.75 | 0.73 | 0.73 | 0.74 | 0.72 | 0.75 |
| EBIT Margin | 0.02 | -0.03 | 0.07 | 0.06 | - | 0.12 |
| Profit Margin | 0.01 | -0.05 | 0.05 | 0.03 | 0.09 | 0.10 |
| EBITDA | 2.1 Million | -4.8 Million | 12.3 Million | 12.02 Million | - | 28.92 Million |
| Earnings Before Tax Margin | 0.02 | -0.05 | 0.05 | 0.05 | 0.12 | 0.11 |
004770
007390
GUJAPOLLO
ATRAV
C3RY
301207